Global OTC Drugs and Devices Market 2022-2028

September 2022 | 76 pages | ID: G16B1EC90900EN
Gen Consulting Company

Abstracts

The global OTC drugs, medical devices and diagnostics market is expected to increase by USD 154 billion, at a compound annual growth rate (CAGR) of 6.9% from 2022 to 2028, according to the latest edition of the Global OTC Drugs and Devices Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global OTC drugs, medical devices and diagnostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the OTC drugs, medical devices and diagnostics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, disease, and region. The global market for OTC drugs, medical devices and diagnostics can be segmented by product: OTC drugs, OTC medical devices. According to the research, the OTC drugs segment had the largest share in the global OTC drugs, medical devices and diagnostics market. OTC drugs, medical devices and diagnostics market is further segmented by disease: cardiovascular diseases (CVDs), diabetes, ENT disorders, gastrointestinal disorders, obesity, orthopedic disorders, respiratory disorders, skin diseases, sleep disorders, others. In 2021, the diabetes segment made up the largest share of revenue generated by the OTC drugs, medical devices and diagnostics market. Based on region, the OTC drugs, medical devices and diagnostics market is segmented into: Asia Pacific, Europe, USA, Rest of the World (RoW). Among these, USA was accounted for the highest revenue generator in 2021.

By product:

• OTC drugs
• OTC medical devices

By disease:

• cardiovascular diseases (CVDs)
• diabetes
• ENT disorders
• gastrointestinal disorders
• obesity
• orthopedic disorders
• respiratory disorders
• skin diseases
• sleep disorders
• others

By region:

• Asia Pacific
• Europe
• USA
• Rest of the World (RoW)

The OTC medical devices and diagnostics market is further segmented into diagnostic devices and kits, self-care devices and wearables. Gen Consulting Company research indicates that the self-care devices and wearables segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years. Furthermore, the OTC drugs and nutritional products/supplements market has been categorized into pharmaceutical OTC drugs, vitamin and mineral supplements. Globally, the pharmaceutical OTC drugs segment made up the largest share of the OTC drugs, medical devices and diagnostics market.

The report also provides analysis of the key companies of the industry and their detailed company profiles including 3M Company, Abbott Laboratories, AbbVie Inc., AKRON Inc., Amgen Inc., Asahi Kasei Corporation, Aspen Pharmacare Holdings Limited, AstraZeneca plc, Baxter International Inc., Bayer AG, Celgene Corporation, Eli Lilly and Company, Johnson & Johnson, Shanghai Pharmaceuticals Holding Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global OTC drugs, medical devices and diagnostics market.
• To classify and forecast the global OTC drugs, medical devices and diagnostics market based on product, disease, region.
• To identify drivers and challenges for the global OTC drugs, medical devices and diagnostics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global OTC drugs, medical devices and diagnostics market.
• To identify and analyze the profile of leading players operating in the global OTC drugs, medical devices and diagnostics market.

Why Choose This Report

• Gain a reliable outlook of the global OTC drugs, medical devices and diagnostics market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

OTC drugs
OTC medical devices

PART 6. MARKET BREAKDOWN BY DISEASE

Cardiovascular diseases (CVDs)
Diabetes
ENT disorders
Gastrointestinal disorders
Obesity
Orthopedic disorders
Respiratory disorders
Skin diseases
Sleep disorders
Others

PART 7. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
USA
Rest of the World (RoW)

PART 8. KEY COMPANIES

3M Company
Abbott Laboratories
AbbVie Inc.
AKRON Inc.
Amgen Inc.
Asahi Kasei Corporation
Aspen Pharmacare Holdings Limited
AstraZeneca plc
Baxter International Inc.
Bayer AG
Celgene Corporation
Eli Lilly and Company
Johnson & Johnson
Shanghai Pharmaceuticals Holding Co., Ltd.
Taisho Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER